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Abstract
The NF-B/REL-family of transcription factors plays a central role in coordinating the expression of a wide variety of
genes controlling immune responses including autoimmunity of the central nervous system (CNS). The inactive
form of NF-B consists of a heterodimer which is complexed with its inhibitor, IB. Conditional knockout-mice for
IBa in myeloid cells (lysMCreIBa
fl/fl) have been generated and are characterized by a constitutive activation of
NF-B proteins allowing the study of this transcription factor in myelin-oligodendrocyte-glycoprotein induced
experimental autoimmune encephalomyelitis (MOG-EAE), a well established experimental model for autoimmune
demyelination of the CNS.
In comparison to controls, lysMCreIBa
fl/fl mice developed a more severe clinical course of EAE. Upon histological
analysis on day 15 p.i., there was an over two fold increased infiltration of T-cells and macrophages/microglia. In
addition, lysMCreIBa
fl/fl mice displayed an increased expression of the NF-B dependent factor inducible nitric
oxide synthase in inflamed lesions. These changes in the CNS are associated with increased numbers of CD11b
positive splenocytes and a higher expression of Ly6c on monocytes in the periphery. Well in accordance with
these changes in the myeloid cell compartment, there was an increased production of the monocyte cytokines
interleukin(IL)-12 p70, IL-6 and IL-1beta in splenocytes. In contrast, production of the T-cell associated cytokines
interferon gamma (IFN-gamma) and IL-17 was not influenced.
In summary, myeloid cell derived NF-B plays a crucial role in autoimmune inflammation of the CNS and drives a
pathogenic role of monocytes and macrophages independently from T-cells.
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Background
Multiple sclerosis (MS) is the most common human
demyelinating disease of the central nervous system
(CNS). The development of autoimmune diseases such as
MS requires the coordinated expression of a number of
pro-inflammatory genes. These factors may influence the
activation, migration and effector function of inflamma-
tory cells and encompass a variety of cytokines, chemo-
kines, adhesion molecules as well as other inflammatory
factors.
Nuclear factor (NF-) kappaB (NF-B) is essential for
both innate and adaptive immunity [1]. NF-Bi sa n
inducible transcription factor which is detected in most
cell types and is involved in many inflammatory pro-
cesses. It consists of homo- or heterodimers of different
subunits and structurally related proteins (Rel/NF-B-
proteins). There are at least five Rel/NF-Bp r o t e i n s :
c-Rel, RelA (p65), RelB, NF-B1 (p50/p105), NF-B2
(p52/p100) [1-4]. The transcriptional activation of the
NF-B pathway is controlled by the inhibitor of NF-B,
IB. IBi sp h o s p h o r y l a t e db yI B kinase (IKK), a com-
plex that is composed of a regulatory subunit IKK-g.
Polyubiquitinylation of IB induces NF-Bd i m e r st o
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over 150 target genes [5].
Besides the involvement of NF-B in T-cell prolifera-
tion and activation [6-8], it is also a key element in coor-
dinately controlling gene expression during monocyte/
macrophage activation [9]. In particular the macrophage-
derived cytokines interleukin-1beta (IL-1 b) and tumor
necrosis factor-alpha (TNF-a), are potent activators of
NF-B. In turn, their expression is controlled by NF-B
thus resulting in a positive feedback loop. Hence, NF-B
signalling pathways may play a pivotal role in activating
myeloid cell function during autoimmune inflammation.
In addition to its central mediatory function in cytokine
expression, NF-B in myeloid cells may be induced by
physical as well as oxidative stress to cells, e.g. via the
inducible nitric oxide synthase (iNOS) [10] or cyclooxy-
genase-2 (COX-2) [11].
In our study, we investigated the role of NF-B in mye-
loid cells during autoimmune demyelination of the CNS.
For the targeted analysis of NF-B functions in mono-
cytes/macrophages, conditional knockout-mice for IBa
in myeloid cells (lysMCreIBa
fl/fl mice) have been gener-
ated [12]. These mice display a constitutive expression of
NF-B proteins in macrophages and monocytes, but no
spontaneous myelopoetic phenotype thus allowing for
studying the role of this transcription factor in myelin-oli-
godendrocyte-glycoprotein induced experimental autoim-
mune encephalomyelitis (MOG-EAE). Our results
demonstrate that NF-B-dependent pro-inflammatory
gene expression in monocytes and macrophages plays an
important role for CNS pathology in autoimmune neu-
roinflammation. In turn, targeting the IKK-NF-Bp a t h -
way in myeloid cells might constitute an interesting
therapeutic target in MS.
Methods
Animals
Conditional knockout-mice for IBa in myeloid cells
(lysMCreIBa
fl/fl mice) have been generated at the Lud-
wigs-Maximilians-University, Munich, Germany [12] and
were backcrossed to the C57BL/6 background for more
than 10 generations. Complete inactivation of IBa
results in hypergranulopoiesis and perinatal death.
Therefore the Cre-loxP recombination system was used
to generate a mouse line that allows for selective deletion
of IBa. The targeting construct was designed in a way
that Cre-mediated recombination results in deletion of
the promoter region containing essential regulatory NF-
B binding sites. These conditional IBk n o c k o u tm i c e
displayed constitutively high nuclear levels of NF-Bi n
myeloid cells. C57BL/6 mice for backcrossing and con-
trols were bred in the same mouse colony. All mice were
housed under pathogen free conditions at the animal
facility of the Ruhr-University Bochum, Germany. All
experiments have been reviewed and approved by the
North-Rhine-Westphalia authorities for animal experi-
mentation. Mice were given food and water at libidum
and were weighed daily to obtain weight curves. All ani-
mal experiments were approved by the local authorities
for animal experimentation (approval ID: 50.8735.1 Nr.
114/6, § 8 Protection of Animals Act). For survival analy-
sis, cohorts of mice were followed over the course of dis-
ease with moribund mice sacrificed according to animal
protection laws.
Induction of EAE
Ten-week-old C57BL/6 female mice and lysMCreIBa
fl/fl
knockout mice were immunized via subcutaneous injec-
tion of 200 μgM O G 35-55 peptide (Charité, Berlin, Ger-
many) in complete Freund’s adjuvant containing 200 μg
Mycobacteria tuberculosis (Difco/BD Biosciences, Hei-
delberg, Germany). All mice received 200 ng pertussis
toxin (List/Quadratec, UK) on days 0 and 2 post immuni-
zation by intraperitoneal injection.
Mice were weighed and scored for clinical signs daily
according to a 10-scale score as described previously
[13].
Splenocyte culture and proliferation assay
For cytokine assays, splenocytes were cultured at 6 × 10
6
cells/well in 24 well plates containing 1 ml in RPMI med-
ium/well (Gibco, Eggenstein, Germany) with various con-
centrations of MOG35-55 peptide, or ConA (1.25 μg/ml).
For the criss-cross proliferation assay, a MACS
® cell
separation (Pan-T-cell kit, Milentyi) for T-cells was used.
Both pooled APC and T-cells were isolated form MOG-
immunized mice on day 10 after immunization. Culture
supernatants for cytokine analysis were collected 48 h
later. For proliferation assays, 0.3 × 10
6 cells/well were
used in 96 well plates. [
3H]thymidine was added to each
culture at 48 h and cells were harvested 16 h later. Data
are depicted as stimulatory index indicating the fold
increase in [
3H]thymidine incorporation as compared to
medium only.
Histological analyses
Mice were deeply anesthetized with ketamine and trans-
cardially perfused with 4% paraformaldehyde in phos-
phate buffered saline (PBS, pH 7.4) for light microscopy
and immunohistochemistry.
Spinal cord was removed, embedded in paraffin and rou-
tinely processed to obtain 12 cross sections per mouse.
Routine stainings comprised cresyl violet staining, Luxol
Fast Blue for myelin and Bielschowsky silver impregnation
for axons. Immunohistochemistry including iNOS staining
(1:200; Millipore, Schwalbach, Germany) was performed
on 3 μm thick paraffin sections. All other histological pro-
cedures were essentially performed as described previously
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Wiesbaden, Germany; 1: 300), macrophages/microglia by
rat anti-mouse Mac-3 (BD Heidelberg, Germany; 1:200)
and neutrophils by rat anti 7/4 antigen (Serotec; 1:300).
Assay of cytokines by ELISA
Cell culture supernatants were collected, aliquoted and
stored at -20°C. Immediately before measurement, aliquots
were brought to room temperature and analyzed for Inter-
leukin (IL) IL-1b, IL-6, IL-12(p40), IL-12(p70), IL-17 and
interferon gamma (IFN-g) using sandwich ELISA kits (BD
and R&D Systems, Minneapolis, USA) according to manu-
facturers’ protocols.
CD11b cell isolation and FACS analysis
Splenic CD11b+ cells were isolated by magnetic cell sort-
ing (MACS) according to manufacturer’s protocols (Milte-
nyi Biotec, Auburn, USA). The purification level of CD11b
+ exceed routinely 95%. The expression of CD11b, CD80,
CD86, MHC class II (MHC-II) and Ly6c was evaluated
both prior and subsequent to MACS using a FACS Canto
II and CellQuest software (BD, Heidelberg, Germany).
Monoclonal antibodies were all purchased from BD.
Quantification and statistical analyses
All neuropathological and scoring analyses were per-
formed completely blinded. All data are presented as
mean ± SEM. Histological quantification was performed
by means of overlaying a stereological grid onto the sec-
tions and counting T-cells, macrophages/microglia, neu-
trophils, iNOS positive profiles and axonal densities on 6
lesions per mouse from representative spinal cord cross
sections comprising cervical, thoracic and lumbar spinal
cord as described previously [13]. Axonal densities were
counted using a 24 point eyepiece from Olympus (Ham-
burg, Germany), and the number of points crossing axons
was measured as a fraction of the total number of points
on the sterological grid [14]. Demyelination was analyzed
semi-automatically with the CellD software (Olympus).
Statistical analysis was performed by Mann-Whitney U-
test for histological evaluations and clinical course, by t-
test, for ELISA and FACS analyses and by two-way
ANOVA with Dunn’s post test for proliferation assays (all
analyses done by Graph Pad Prism 5, San Diego, CA,
USA). In all experiments, a probability level of *p < 0.05,
**p < 0.01, ***p < 0.001 was considered to be statistically
significant.
Results
Characterization of mice with a conditonal IB deletion in
myeloid cells
In this study, we employ lysMCreIBa
fl/fl mice to analyze
t h er o l eo fN F - B in monocytes during autoimmune
inflammation. While these mice have been characterized
in detail before [12], we analyzed the expression of
the active, phosphorylated p65 NF-B subunit in
naive monocytes by confocal laser scanning microscopy
(Figure 1). To this end, CD11b-positive monocytes from
lysMCreIBa
fl/fl or wild-type control mice were isolated
a n du s e df o ra n t i - N F - B-p65 immunocytochemistry.
Double label experiments with TOTO-3 as nuclear stain-
ing revealed that naive monocytes from lysMCreIBa
fl/fl
mice showed constitutive activity of p65 in monocytes
while there was no NF-B activation in naive monocytes
from wild-type controls. In summary, naive monocytes
from lysMCreIBa
fl/fl mice are characterized by an
increased activity of the NF-B system and constitute a
useful tool to study the role of NF-Bi nm o n o c y t e sd u r -
ing autoimmune inflammation.
We next investigated the functional impact of the condi-
tonal IB deletion in naive CD11b positive splenocytes
and in particular CD11b/Ly6c positive monocytes via
FACS (Figure 2A, B). We observed a significantly higher
number of spleen-derived CD11b positive cells and a
higher total cell count of CD11b/Ly6c double positive cells
in spleens from lysMCreIBa
fl/fl mice (Figure 2B, Table 1).
FACS analyses of CD11 positive cells after MACS sorting
did not reveal any significant differences in the expression
of CD80, CD86 and MHC-II (Figure 2C). However,
expression of Ly6c was significantly increased on CD11b
cells from lysMCreIBa
fl/fl mice (Figure 2D).
Constitutive activation of NF-B in myeloid cells leads to
a more severe course of MOG-EAE with enhanced
inflammatory infiltration and demyelination
To investigate the role of a constitutive activation of NF-
B in myleoid cells during autoimmune neuroinflamma-
tion, we analyzed clinical symptoms and disease severity of
MOG-EAE in lysMCreIBa
fl/fl mice as compared to age
and gender matched wild-type control mice (Figure 3).
Disease incidence and mortality from EAE did not differ
between groups (wild-type mice n = 13 and lysM-
CreIBa
fl/fl mice n = 14). However, lysMCreIBa
fl/fl mice
displayed a significantly more severe clinical course of
EAE. On day 20 post immunization, conditional knock-
out mice suffered from severe paraparesis while mice in
the control group only displayed severe gait ataxia.
Next, we focused on histological analyses to determine
whether the clinical differences between groups corre-
lated with enhanced infiltration of inflammatory cell sub-
sets in the CNS as well as demyelination and axonal
damage. Upon histological analysis of spinal cord cross
sections on day 15 post immunization, there was an
increased number of inflammatory infiltrates and an
increased infiltration of CD3 positive T-cells as well as
Mac-3 macrophages/microglia and an increased amount
of iNOS positive cells in lysMCreIBa
fl/fl mice (Table 2
and Figure 4). The analysis of myelin loss after Luxol Fast
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tion in lysMCreIBa
fl/fl mice (Figure 4). Upon evaluation
of axonal densities after Bielschowsky silver impregnation
as well as numbers of iNOS positive cells and infiltrating
7/4-antigen positive neutrophils, there was a trend
towards enhanced axonal injury as well as an increased
neutrophil infiltration in lysMCreIBa
fl/fl mice, but with-
out statistical significance (Table 2).
We also examined inflammatory infiltration at a later
time point (day 30 p.i.) which revealed less inflammation,
but a similar trend towards enhanced inflammatory infil-
tration in lysMCreIBa
fl/fl mice (data not shown).
Constitutive activation of NF-B in myeloid cells results in
increased monocyte cytokine production
Since we found a more severe EAE with enhanced inflam-
matory infiltration in lysMCreIBa
fl/fl mice, we next
examined the involved immunological processes in this
model. To this end, we analyzed T-cell proliferation and
cytokine production in splenocyte primary cultures from
MOG-immunized mice after recall with MOG antigen. In
co-culture experiments of wild-type T-cells with lysM-
CreIBa
fl/fl antigen presenting cells and vice versa, we
found an increased T-cell proliferation specifically after
culture of lysMCreIBa
fl/fl T-cells with lysMCreIBa
fl/fl
APC and after stimulation with ConA (Figure 5). Upon
analysis of IL-1b, IL-6, and IL-12(p40/70) after re-stimula-
tion with MOG in splenocyte culture (Figure 6A-D), there
was a significant increase of the NF-B dependent mono-
cyte cytokines IL-1b, IL-6 and IL12p70 in the supernatant
from lysMCreIBa
fl/fl mice as compared to controls (Fig-
ure 6B-D). In contrast, production of the T-cell cytokines
IL-17 and IFN-g was not influenced (Figures 6E, F).
In summary, lysMCreIBa
fl/fl mice displayed an
altered monocyte cytokine profile which was associated
with an increased production of IL-1b, IL-6, and IL-12
(p70) in splenocyte culture.
Discussion
Here we analyze the role of monocyte/macrophage derived
NF-B in autoimmune demyelination. We studied EAE in
mice which are devoid of IBa in myeloid cells (lysM-
CreIBa
fl/fl mice). In these mice, loss of IB in monocytes
and macrophages leads to constitutive expression of NF-
B. In turn, this results in an increased expression of NF-
B regulated monocyte/macrophage cytokines and subse-
quently enhanced macrophage infiltration and iNOS
expression in the spinal cord of EAE mice. These mechan-
ims govern demyelination, enhanced axonal damage and
f i n a l l yam o r es e v e r ec o u r s eo fM O G - E A E .T h u sm a c r o -
phage derived, NF-B dependent cytokines may play a
pivotal role in the pathogenesis of EAE and determine the
outcome of autoimmune inflammation in the CNS with-
out interfering with Th1 and Th17 T-cell responses. Our
f i n d i n g ss u g g e s tt h a tN F - B in myeloid cells is a master
regulator for regulation of inflammation and tissue
damage in autoimmune inflammation of the CNS.
Previous studies already investigated the role of NF-B
in the CNS [15], in autoimmune diseases [16] and also
during EAE. The analysis of c-Rel or NF-B1-deficient
mice as well as IKK-2-deficient mice revealed that NF-B
activation in T-cells significantly contributes to the initia-
tion of autoimmune neuroinflammation [17,18]. Myelin-
specific T-cells in NF-B1 (p50)-deficient mice are defi-
cient in differentiating into either Th1 or Th2 cells [17].
This concept was further refined by Dasgupta and co-
Figure 1 Constitutive activation of NF-B in lysMCreIBa
fl/fl monocytes. Representative cytospins of naïve CD11b-sorted spleen monocytes
from lysMCreIBa
fl/fl mice (A) or wild-type controls (B) after staining for the NF-B p65 subunit and nuclear co-staining with TOTO-3. Note the
accumulation of active NF-B in the nucleus of monocytes from a representative lysMCreIBa
fl/fl mouse (marked by arrows). Bar = 20 μm.
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fl/fl mice. (A) Analysis of spleen cells from naïve lysMCreIBa
fl/fl mice (n = 7) and wild-type mice (n
= 8). Isotype controls are coloured in red, CD11b+ cell fractions are marked with a yellow box. (B) FACS analyses show a significantly increased
number of spleen-derived CD11b positive monocytes and CD11b/Ly6c double positive cells in lysMCreIBa
fl/fl mice. Data are shown in per cent
of total cell count. (C) lysMCreIBa
fl/fl mice display a non significant increase of the co-stimulatory molecules CD80 and CD86. While there is no
effect on MHC-II (C), there is a significant increase in Ly6c expression on CD11b+ cells from lysMCreIBa
fl/fl mice (D).
Table 1 FACS analyses
lysMCreIBa
fl/fl wild-type p-value n
% of CD11b positive spleen cells [± SEM] 11.5 ± 1.3 6.2 ± 1.0 0.0003 7/8
absolute numbers of CD11b positive spleen cells [± SEM] 2299.7 ± 98 1246 ± 69 0.0003 7/8
Quantification of CD11b positive spleen cells. 20.000 cells/mouse were analyzed.
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ferentiation of myelin-specific Th1 cells, but a negative
influence on the differentiation into Th2 cells [19]. In
line with these observations, severely impaired T-cell
responses were found in immune cell cultures derived
from mice with a T-cell specific deficiency in IKK2, a
pivotal kinase for NF-Ba c t i v a t i o n( I K K 2
Δ T-cell mice)
[20].
Moreover, NF-B may also play a role in the CNS
cells during autoimmune demyelination. While studies
by Wooten or Mattson and co-wokers in cell culture
a r g u ef o rap r o t e c t i v er o l eo fN F - B in neuronal cells
[21,22], our work with conditional overexpression of
NF-B in myeloid cells reveal monocytes/macrophages
as a further cell type with crucial importance of NF-B
in neuroinflammation.
Many studies have demonstrated a critical role for
macrophages/microglia as well as an up-regulation of
MHC class II in these cells in EAE and MS lesions
[23,24]. Depletion experiments with liposomal dichloro-
methylene diphosphonate (Cl2MDP) revealed a crucial
role of bone marrow derived macrophages for tissue
damage in EAE [25,26]. Interestingly, histological ana-
lyses in these studies could not detect differences in
number and localization of CNS infiltrating T-cells
between Cl2MDP treated rats and controls [25]. These
Figure 3 The clinical course of MOG-EAE in lysMCreIBa
fl/fl mice is more severe. Clinical course of EAE in wild-type mice (n = 13) and
lysMCreIBa
fl/fl mice (n = 14). lysMCreIBa
fl/fl mice (black curve) show a significantly earlier start and a more severe course of disease compared
to wild-type mice (grey curve). Data represent the mean of two independent experiments ± SEM.
Table 2 Histological analyses
lysMCreIBa
fl/fl wild-type p-value n
Inflammatory Index [± SEM] 16.0 ± 1.9 6.8 ± 1.0 0.0003 5/5
CD 3 [cells/mm
2 ± SEM] 251 ± 19 102 ± 13 < 0.0001 5/5
Mac-3 [± SEM] 1123 ± 81 581 ± 100 < 0.0001 5/5
iNOS [± SEM] 333 ± 75 153 ± 19 0.0184 5/5
% Demyelination [± SEM] 8 ± 0.8 2 ± 0.6 < 0.0001 5/5
Neutrophils [± SEM] 339 ± 37 190 ± 25 n.s 5/5
Axonal densities [± SEM] 3.7 ± 0.5 2.9 ± 0.3 n.s 5/5
Blinded quantification of the inflammatory index after HE-staining, CD3 positive cells, Mac-3 positive macrophages/microglia, iNOS positive cells, demyelination
after Luxol Fast Blue staining and axonal densities after silver impregnation were performed on day 15 p.i. marking the acute phase of the disease. Data are
presented as cells/mm
2 for CD3, Mac-3, iNOS positive cells, percent demyelination for Luxol Fast Blue and relative axonal densities for silver impregnated axons.
n.s = not significant.
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tion in EAE. Well in line with this concept, we did not
observe any change in T-cell cytokine expression in our
model. Indeed, not monocytes/macrophages, but rather
dendritic cells as professional antigen presenting cells do
play the major role for T-cell activation in EAE [27].
Furthermore, lysMCre mediated IBa deletion in our
model does not involve dendritic cells and does not lead
Figure 4 Enhanced inflammatory infiltration, demyelination and iNOS expression in lysMCreIBa
fl/fl mice. Histological analyses of
lysMCreIBa
fl/fl mice (A, C, E, G) versus wild-type mice (B, D, F, H) result in increased inflammatory infiltration after HE staining or Mac-3 staining
(A, B, C, D) and increased demyelination after Luxol Fast Blue staining (E, F). As compared to wild-type controls, lysMCreIBa
fl/fl mice are also
characterized by an increase in iNOS expression cells (G, H). Representative images of spinal cord cross section in the acute phase on day 15
post immunization are shown. Infiltrated areas are marked in the knockout-mice group (A). Scale bar is only depicted in (H) for clarity and
represents 200 μm for A, B, E, F and 20 μmi nC ,D ,G ,H .
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in macrophages/monocytes may be more important for
effector functions than for T-cell activation. Yet, changes
in phagocyte cytokine patterns may eventually result in
an enhanced T-cell activation over time which is not
reflected in our analysis at day 10 after immunization.
Further studies are warranted to dissect indirect effects
of myeloid cell derived NF-B on T-cell function in the
setting of chronic inflammation.
Our data reveal a crucial role of myeloid cell derived
NF-B for demyelination. In our model, demyelination
or oligodendrocyte apoptosis may be mediated by a
direct phagocytic attack of macrophages or also by
macrophage derived toxic cytokines. Here, especially
TNF-a as a typical NF-B regulated cytokine in
macrophages may play a role [28]. Previous studies
already indicated a major role of TNF-a for macrophage
recruitment from the periphery [29] and also for oligo-
dendrocyte apoptosis as well as toxic demyelination,
especially in the MOG-EAE models of the C57BL/6
mouse [30,31]. Finally, myelin loss might also be influ-
enced by free radicals. As shown, overexpression of NF-
B may lead to an increased expresion of the NF-B
target gene inducible NO-synthase (iNOS) and thus an
increased NO production which was previously shown
to exert a detrimental role on oligodendrocytes and in
EAE [32,33].
Moreover, reactive oxygen species (ROS) intermedi-
ates may induce cellular damage and trigger demyelina-
tion as well as a recently shown reversible axonal
Figure 5 Increased T-cell proliferation with APC from lysMCreIBa
fl/fl mice. Analysis of T-cell proliferation in splenocyte primary cultures
from MOG-immunized mice after recall with MOG antigen. Data from a representative splenocyte culture experiment with n = 4 for each group
are shown. All data are depicted as stimulatory index and expressed as mean ± SEM. Note the increased T-cell proliferation specifically after
culture of lysMCreIBa
fl/fl T-cells with lysMCreIBa
fl/fl mice APC and after stimulation with ConA.
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Page 8 of 11Figure 6 Increased expression of NF-B dependent monocyte/macrophage cytokines in splenocyte primary culture.E L I S Ab a s e d
analysis of cytokines in a MOG35-55 recall assay from splenocyte cultures. Data from a representative splenocyte culture experiment with n = 4
for each group are shown. All data are expressed as mean ± SEM. While production of interleukin IL-12p40 (A) is similar between both groups,
lysMCreIBa
fl/fl mice are characterized by an increased production of the NF-B dependent cytokines IL-12p70 (B), IL-1b (C) and IL-6 (D). In
contrast, production of the T-cell cytokines IL-17 (E) and interferon gamma (IFN-g, F) is not influenced.
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this process, ROS mediated NF-B activation [35] and
in turn NF-B induced further ROS production in
macrophages may play an important role. This notion is
underscored by the fact that macrophages were found
to play an important role in the process of ROS
mediated FAD [34].
In our model, further pathways in NF-Ba c t i v a t i o n
may be involved. Among others, these factors may
include toll-like receptors (TLR). In EAE, especially
TLR9 on microglia may play an important role for inter-
action with invading immune cells and for the initiation
of a cascade resulting in NF-B activation and finally an
enhanced innate immune responses [36].
Theoretically, NF-B overexpression in macrophages
may also exert protective effects in EAE. Indeed, overex-
pression of the NF-Bt a r g e tg e n e“triggering receptor
expressed on myeloid cells 2” (TREM2) in myeloid cells
lead to an enhanced expression of anti-inflammatory
cytokines in the spinal cord of EAE mice as well as a
reduced amount of demyelination and axonal damage
[37]. In our setting, overexpression of NF-B in macro-
phages predominantly induces destructive effects thus
arguing for the prevailing importance of NF-B mediated
pathways for detrimental phagocyte functions in EAE.
Conclusions
In summary, our results identify immune-mediated
pathways in myeloid cells and in particular monocyte/
macrophage derived NF-Ba sap o t e n t i a lt a r g e tf o r
therapeutic interventions in the treatment of autoim-
mune diseases such as MS. This concept is well in line
with previous studies using lysMCre mediated condi-
tional gene targeting in macrophages. The myeloid cell
specific deletion of the type I interferon receptor also
revealed these phagocytes as an interesting therapeutic
target in autoimmune neuroinflammation [38].
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